PAPERS - RESEARCH FRONT: 3

TITLE 1ST AUTHOR YEAR
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease Korth C 2001
Identification of the heparan sulfate binding sites in the cellular prion protein Warner RG 2002
Potential risk of bovine spongiform encephalopathy (BSE) to human beings and therapeutic approaches to prion disease Kaneko K 2002
Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases Diaz-Nido J 2002
Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model Collins SJ 2002
Protein conformation and diagnostic tests: The prion protein Bennion BJ 2002
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines May BCH 2003
Potential treatments and treatment strategies in Creutzfeldt-Jakob disease Macleod MA 2003
Pentosan polysulfate as a prophylactic and therapeutic agent against prion disease Dealler S 2003
Differential inhibition of prion propagation by enantiorners of quinacrine Ryou C 2003
Therapeutic approaches in prion disease Hachiya NS 2003
Prion diseases: From molecular biology to intervention strategies Nunziante M 2003
Prion diseases and the "protein only" hypothesis Zhou JM 2004
Quinoline derivatives are therapeutic candidates for transmissible spongiform encephalopathies Murakami-Kubo I 2004
Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrP degradation Perrier V 2004
Prion diseases - Close to effective therapy? Cashman NR 2004
Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations Crozet C 2004
Pharmacokinetics of quinacrine in the treatment of prion disease Yung L 2004
Semiautomated cell-free conversion of prion protein: Applications for high-throughput screening of potential antiprion drugs Breydo L 2005
PrPSc incorporation to cells requires endogenous glycosaminoglycan expression Hijazi N 2005